中西医结合肝病杂志2025，Vol.35Issue(7)：793-796,4.DOI:10.3969/j.issn.1005-0264.2025.007.001
应用"择期辨证"理论治疗原发性肝癌
Study and exploration on the treatments of primary liver cancer based on the theory of selective period syndrome differentiation
摘要
Abstract
The treatments of primary liver cancer(PLC)require multidisciplinary collaboration,orderly integration of multiple approaches,synergistic action of multiple targets,and systematic multi-temporal syndrome differentiation.Professor Hu Zhenbin,as the leader of the Key Specialty(Hepatology)under the State Administration of Traditional Chinese Medicine,has been dedicated to scientific research and clinical practice in the prevention and treatment of liver diseases for over 30 years,accumulating a wealth of clinical experiences.In the diagnosis and treatment of PLC,Professor Hu follows the theory of"Selective Period Syndrome Differentiation",adheres to the view of"Dynamic Pathogenesis",implements the principle of"Stage-specific Treatment"and establishes a new"four-in-one"diagnostic and treatment model that integrates location,nature,trend,and stage of the disease.This approach aims to continuously improve the understanding of PLC at various stages by both TCM and Western medicine,leverage the synergistic advantages of their combined diagnosis and treatment,and provide new ideas and perspectives for the precise treatment of PLC with TCM.关键词
原发性肝癌/择期辨证/学术经验Key words
primary liver cancer/selective period syndrome differentiation/academic experience分类
医药卫生引用本文复制引用
唐秋媛,胡世伟,胡振斌,周晓玲,毛德文,庞宇舟,石清兰,吕建林,王秀峰,吕超..应用"择期辨证"理论治疗原发性肝癌[J].中西医结合肝病杂志,2025,35(7):793-796,4.基金项目
国家自然科学基金(No.82160881,82460901,82160888,82060847) （No.82160881,82460901,82160888,82060847）
